BENZYL (1-(METHOXY(METHYL)AMINO)-1-OXOPROPAN-2-YL)CARBAMATE, 95.0%, 250mg

methyl 3-{[(2H-1,3-benzodioxol-5-yl)methyl]amino}butanoate, 95.0%, 2g

(S)-1-(6-Bromopyridin-2-yl)ethanamine, 95%, 100mg

2,2,2-trifluoroetanol, mínimo 99,8 %, para síntesis, 100 ml, envase de vidrio

(S)-3-Hydroxybutanoic acid methyl ester, 95.0%, 500g

pyrimidine-4-carbaldehyde, 95.0%, 5g

4-VINYLDIHYDROFURAN-2(3H)-ONE, 95.0%, 5g

Embudo de decantación cilíndrico con grifos de cristal, 250 ml, 2 Unidad(es)

2-Methyl-[1,1'-biphenyl]-3-carbaldehyde, 97%, 25g

2-Oxa-5-azabicyclo[4.1.0]heptane hydrochloride, 95.0%, 500mg

4-N-Boc-Aminobenzooxazol, 97.0%, 1g

TERT-BUTYL 3-(PIPERIDIN-3-YL)AZETIDINE-1-CARBOXYLATE, 95.0%, 25g

Ipatasertib, 99.88%, 250mg